The First Live-Cell Based Product in The Iranian Drug List; ReColorCell®

Mohammad Amin Shahrbaf, Leila Ataei Fashtami, Massoud Vosough

Open source

DOI: 10.22074/cellj.2023.1978336.1183
Published: 3
Container: Cell Journal
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.22074/cellj.2023.1978336.1183,
  title = {The First Live-Cell Based Product in The Iranian Drug List; ReColorCell®},
  author = {Mohammad Amin Shahrbaf and Leila Ataei Fashtami and Massoud Vosough},
  year = {2023},
  journal = {Cell Journal},
  doi = {10.22074/cellj.2023.1978336.1183},
  url = {https://doi.org/10.22074/cellj.2023.1978336.1183}
}

RIS

TY  - JOUR
TI  - The First Live-Cell Based Product in The Iranian Drug List; ReColorCell®
AU  - Mohammad Amin Shahrbaf
AU  - Leila Ataei Fashtami
AU  - Massoud Vosough
PY  - 2023
JO  - Cell Journal
DO  - 10.22074/cellj.2023.1978336.1183
UR  - https://doi.org/10.22074/cellj.2023.1978336.1183
ER  -

APA

Shahrbaf, M. A., Fashtami, L. A., & Vosough, M. (2023). The First Live-Cell Based Product in The Iranian Drug List; ReColorCell®. Cell Journal. https://doi.org/10.22074/cellj.2023.1978336.1183

Source records

doaj · retrieved 2026-09-26T23:53:23.502Z